Seaport Global Advisors, LLC United Therapeutics Corp Transaction History

Seaport Global Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $253,548 - $297,143	1,197 Added 47.03%	3,742 $845,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $89,873 - $102,049	438 Added 20.79%	2,545 $561,000
Q1 2023 May 23, 2023	BUY	$212.99 - $276.17 $34,504 - $44,739	162 Added 8.33%	2,107 $471,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $261,556 - $356,146	1,270 Added 188.15%	1,945 $540,000
Q3 2022 Nov 21, 2022	BUY	$203.3 - $244.17 $25,819 - $31,009	127 Added 23.18%	675 $141,000
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $95,795 - $132,144	548 New	548 $129,000

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Seaport Global Advisors, LLC with notifications on news.